3Olson R M, Perencevich N P, Macolm A W, et al. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer, 1980, 45(12):2969-2974.
4Curley S A, Carlson G W, Shumate C R, et al. Extended resection for locally advanced colorectal carcinoma. Am J Surg, 1992,163(6):553-559.
5Michelassi F, Vannucci L, Ayala J J, et al. Local recurrence after curative resection of colorectal adenocarcinoma. Surgery, 1990,108(4):787-793.
6Carraro P G, Segala M, Cesana B M, et al. Obstructing cotonic cancer:failure and urvival patterns over a ten-year followup after one stage curative surgery[J].Dis Colon Rectum, 2001, 44:243- 250.
7Garcia A J, Cromwell J W, Marra C, et al, Treatment of locally recurrent rectal cancer [J]. Dis Colon Rectum, 2001, 44:1743- 1748.
5Wolpin BM,Michaud DS,Giovannucci EL. Circulation insulin-like growth factor binding protein-1 and the risk of pancreatic cancer[J].Cancer Research,2007,(16):7923-7928.
6Sridhar SS,Goodwin PJ. Insulin-insulin-like growth factor axis and colon cancer[J].Journal of Clinical Oncology,2009,(02):165-167.
7Ouban A,Muraca P,Yeatman T. Expression and distri-bution of insulin-like growth factor-Ⅰ receptor in human car-cinomas[J].Human Pathology,2003,(08):803-808.
8Sugumar A,Liu YC,Xia Q. Insulin-like growth factor (IGF)-Ⅰ and the risk of premenopausal breast cancer:a meta-analysis of literature[J].International Journal of Cancer,2004,(02):293-297.doi:10.1002/ijc.20253.
9Pechlivanis S,Wagner K,Chang-claude J. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer[J].Cancer Detection and Prevention,2007,(05):408-416.
10Yang L,Li J,Ran L. Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells[J].Journal of Gastrointestinal Surgery,2011,(06):942-957.
